Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Florida Biologix Meets EU Compliance | Contract Pharma

What are you searching for?

Sign in
Breaking News

Florida Biologix Meets EU Compliance

Expands aseptic fill-finish capabilities for clinical biologics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Florida Biologix has met European GMP requirements for aseptic fill-finish for biopharmaceutical drug products. The company can now provide aseptic fills for European clinical trials for filling Phase I/II drug products into vials or other containers.

Florida Biologix provides either manual or automated filling services of as much as 4,000 vials per lot, including formulation and filling of complex biologic products such as proteins, protein complexes, adjuvanted vaccines, oligonucleotides, liquid small molecules and other parenterals. Associated services include drug product in-process and release testing, labeling, packaging, cGMP storage, stability studies, blind labeling, and distribution to clinical study sites.

In addition, the company has recently invested in GMP facility improvements and equipment, as well as additional classified support space and is adding new warehouse areas. The associate director of Florida Biologix, Dr. Joyce Francis, said, “These improvements support our multi-year production contracts. As our business grows, we continue to make investments to improve our state-of-the-art facility and overall capabilities.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics